About Us

Wearable devices are becoming an everyday companion. At Sensifree, we are pioneering the landscape of contactless sensors for wearables. We work closely with manufacturers of wearables and understand real-life challenges of new wearable devices.
Our mission is to provide sensors that will make wearables comfortable, accurate and consume low power. Our sensor technology is unique and we are making it affordable for the consumer market. Our heart rate sensor is already available and we are currently developing a revolutionary, cuff-less blood pressure sensor.

The Vision

Sensifree has developed a unique, patent-pending sensor technology that solves the shortcomings of optical sensors. Our RF based sensor technology can accurately monitor heart rate from different points on the human body. Unlike current LED optical technology, Sensifree sensors are very low power, deliver robust operation, and give designers and manufacturers the ability to create new wearable products that do not compromise comfort, appearance or usability.

Sensifree partners with wearable manufacturers, fashion brands and luxury watch makers seeking next generation biometric sensors for consumer electronics devices, fitness trackers, traditional watches and smart clothing products.

About Us

Sensifree develops the future of blood pressure monitoring devices, replacing 19th century technology and methods. We provide cuff-free, comfortable, and discrete continuous monitoring of this critical vital sign. We use our proprietary, RF based technology to generate a unique signal from the radial artery and evaluate systolic and diastolic pressures from it.
We aim at revolutionizing the diagnosis and management of hypertension by bringing a new standard of care to clinics, home healthcare and hospitals.
Our first target is hypertension diagnosis and remote patient monitoring, then expanding into consumer healthcare and bedside patient monitoring.

Technology

Sensifree developed a breakthrough solution for cuff-free blood pressure monitoring. It is based on our proprietary patent pending RF technology. Our wrist worn device generates a unique signal originated at the radial artery, accurately tracking the dimensions of the pulsating blood vessel, thus generating a continuous arterial pressure wave signal. We then use proprietary algorithm to evaluate and track systolic and diastolic blood pressure values. Our revolutionary approach is substantially different from other proposed solutions, as our sensor generates a signal originated at the artery, which is directly related to the blood pressure inside it. We use a proprietary algorithm, based on modeling of the cardiovascular system, to calculate both systolic and diastolic pressure values.
Our solution comprises of a connected monitoring wearable device, and a cloud processing and storage backend system. The system automatically generates measurement reports with actionable data. In the future, contextualized, cloud based data will be used to identify trends and patterns for early identification and alerts of medical conditions.
We recently entered into research partnership with the prestigious Swiss research organization CSEM. This partnership augments our R&D capabilities and validates our scientific approach.

With every beat of the heart a pressure wave is created, traveling down the arteries. The blood pressure inside the arteries is constantly changing between its systolic and diastolic values. This periodic increase and decrease in blood pressure creates a distention in the artery wall.

Sensifree has developed and miniaturized RF based technology that senses artery distention for measuring blood pressure.

image001

Applications

High Blood Pressure Diagnosis and Management

Hypertension (High Blood Pressure) is the largest epidemic known to mankind. More than 1B people globally are living with high blood pressure[1]. It is a major risk factor for various cardiovascular diseases and stroke – leading causes of death in the US and in most developed countries. Since high blood pressure has no symptoms, less than half of adults with high BP in the US have the condition under control or even diagnosed[2].

Because a single blood pressure measurement taken at a doctor’s office is meaningless for the purpose of diagnosis, high blood pressure is diagnosed today mostly based on data measured at home, using patient-owned devices. This methodology is often inaccurate and missing important information: over diagnosis due to anxiety, under diagnosis due to masked hypertension, and does not provide monitoring of nocturnal (night time) BP, which is important in the overall assessment of patient’s condition.

It is widely accepted that the best method to diagnose high blood pressure and assess effectiveness of treatment is by a 24 hour continuous blood pressure monitoring session. It is the gold standard in the US, Europe, Canada and Japan[3][4][5][6].

 

 

[1]Worldwide trends in blood pressure from 1975 to 2015 – The Lancet, Nov. 15, 2016
[2]Assessing the Importance of Ambulatory Blood Pressure Monitoring for Hypertensive Patients – a CDC paper
[3]Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement – Albert L. Siu, MD, MSPH, on behalf of the U.S. Preventive Services Task Force – Annals of Internal Medicine, Vol. 163 No. 10, 17 November 2015
[4]European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
[5]http://guidelines.hypertension.ca/diagnosis-assessment/ambulatory-measurement/
[6]Management of hypertension: summary of NICE guidance

Blood Pressure Monitoring Redefined

Our first product is a revolutionary blood pressure monitor, aiming at setting a new standard of care for hypertension diagnostics and serve as a remote patient monitoring guardian.
Based on our proprietary RF technology and advanced algorithms, it offers a compelling value proposition for both patients and clinicians –
• Ease of use – cuff-free, comfortable, lightweight, wireless connectivity.
• Automatic blood pressure monitoring – uninterrupted daily activities, sleep time monitoring.
• Tracking, storing and reporting – producing actionable reports, trend analysis, alerts to improve medication adherence.

watch_render_colored_metals.66

News

CSEM2

CSEM And Sensifree Announce Research Partnership

Exploring ultra-low-power sensors for cuff-less blood pressure monitoring

Neuchâtel (CH), Cupertino, CA (US), and Petach-Tikva (IL); January 23, 2017—Sensifree and CSEM join forces to create a disruptive technology for monitoring blood pressure without using a cuff. Combining CSEM’s expertise in the field of blood pressure monitoring and Sensifree’s novel, RF-based approach will pave the way for the production of a new tool for the highly attractive health wearables market. Click for more details

0

Sensifee was selected as one of EE Times Silicon 60:
2016’s Emerging Companies to Watch

Sensifree Ltd. (Cupertino, Calif.) was founded in 2012 and claims to have developed a contact free, electromagnetic sensor that accurately collect a range of continuous biometric data without the need to touch the human body. The Sensifree technology uses RF signal to sense movement in the radial artery wall to track heart rate, and in the future blood pressure. Having taken the pulse digital signal processing is used to extract more information. Click for the full article

0-1

Sensifree Secures $5M in Series A Financing Led by TransLink Capital

Cupertino, CA and Petach-Tikva, Israel, May 24, 2016 — Sensifree, the pioneer in low power, contact free, electromagnetic sensors that accurately collect a range of continuous biometric data without the need to touch the human body, today announced it has completed a $5.0 million Series A round of financing. TransLink Capital led the investment round with participation from existing and new investors, including UMC Capital, a subsidiary of United Microelectronics Corp. (NYSE: UMC) and an undisclosed strategic investor.

Read More
sensifree-samsung

Sensifree showcasing contactless heart rate sensor at SDC 2014 in San-Francisco

Sensifree is proud to take part in Samsung’s digital health program. Being a Samsung technology partner from the early stages of the development of the Simband wearable platform, Sensifree developed a heart rate sensor module for Simband based on its contactless sensor technology. This technology partnership and sensor was announced and showcased at the Samsung Developers Conference 2014 held in November in San-Francisco.

Meet the Team

Eran Agmon

Eran Agmon

CEO & Co-founder

Eran is a veteran of the technology industry, with over 20 years of experience in various companies, both mature and startups, in which he held executive and senior level positions in corporate development, product strategy and marketing. Eran brings with him proven experience in developing new businesses from scratch, with strong multidisciplinary technical background. Eran holds a B.Sc.EE degree from the Tel-Aviv University. Prior to founding Sensifree Eran worked at Gilat Satellite Networks, Camero-Tech and Raysat Antenna Systems.

Ilan Barak

Ilan Barak

CTO & Co-founder

Ilan is an expert in microwaves, RF and chip design. With over 35 years of experience in the Israeli hi-tech industry and more than 20 patents filed by him, Ilan leads the technological innovation in Sensifree. Ilan holds B.Sc and M.Sc degrees in electrical engineering, both from the Tel-Aviv University.

Lior Haviv

Lior Haviv

COO & Head of R&D

A technology executive with 25 years of experience in R&D and corporate management in positions including VP at a start-up company and R&D director in a multinational corporation, leading organizations covering a wide range of systems, hardware and software disciplines, with significant involvement in Operations, QA and pre- and post-sales support.

Board Members

Contact Us

Your Name*

Last Name*

Phone

Email*

Company

Title

Interested In

Question/Inquiry

info@sensifree.com

US Headquarters: 21631 Stevens Creek Blvd. Suite #B, Cupertino, CA 95014, USA| Tel: +1-408-913-5574

R&D Center: 10 Hamefalsim St., Petah Tikva, ISRAEL | Tel: +972 3 559 8990 | Fax: +972 3 559 8994